The global market for Artificial Intelligence in Epidemiology was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
China and the United States are two leaders in AI industry. On the AI 100 list (2022) released by CB Insights, the number of companies in the United States ranks first, with more than 70 companies, followed by the United Kingdom, with 8 companies on the list. China and Canada both holds 5 companies on the list. According to data from the China Academy of Information and Communications Technology, the scale of China's core artificial intelligence industry reached 楼508 billion in 2022, a year-on-year increase of 18%. From 2013 to November 2022, the cumulative number of patent applications for artificial intelligence inventions in the world reached 729,000, and the cumulative number of applications in China reached 389,000, accounting for 53.4%. However, the Global Artificial Intelligence Innovation Index Report 2021 released by the China Institute of Scientific and Technological Information shows that the overall strength of the United States is still far ahead. The number of artificial intelligence companies in the United States is about 4,670, while China has only 880. China's data center is less than 1/120 of that of the United States.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence in Epidemiology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Artificial Intelligence in Epidemiology by region & country, by Type, and by Application.
The Artificial Intelligence in Epidemiology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence in Epidemiology.
麻豆原创 Segmentation
By Company
Abbott Informatics
AdvancedMD
Agilent Technologies
Allscripts Healthcare
Athenahealth
Autoscribe Informatics
Cerner Corporation
Change Healthcare
Cognizant
CPSI
CureMD Healthcare
eClinicalWorks
e-Mds Inc.
Epic Systems
GE Healthcare
Google
Graphcore
Greenway Health
IBM
Intel
InterSystems
Kareo
Medhost
Meditech
Medtronic
Micron Technology
Microsoft
NextGen Healthcare
Nvidia
Optum Inc.
Segment by Type:
Hardware Technology
Software Technology
Segment by Application
Disease and Syndromic Surveillance
Infection Prediction and Forecasting
Immunization Information Systems
Public Sentiment Analysis
Environmental Impact Analysis
Drug Discovery, Safety, and Risk Analysis
Monitoring Population and Incidence
Knowledge Representation and Mass Notification
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Artificial Intelligence in Epidemiology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Artificial Intelligence in Epidemiology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Artificial Intelligence in Epidemiology in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Artificial Intelligence in Epidemiology Product Introduction
1.2 Global Artificial Intelligence in Epidemiology 麻豆原创 Size Forecast
1.3 Artificial Intelligence in Epidemiology 麻豆原创 Trends & Drivers
1.3.1 Artificial Intelligence in Epidemiology Industry Trends
1.3.2 Artificial Intelligence in Epidemiology 麻豆原创 Drivers & Opportunity
1.3.3 Artificial Intelligence in Epidemiology 麻豆原创 Challenges
1.3.4 Artificial Intelligence in Epidemiology 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Artificial Intelligence in Epidemiology Players Revenue Ranking (2023)
2.2 Global Artificial Intelligence in Epidemiology Revenue by Company (2019-2024)
2.3 Key Companies Artificial Intelligence in Epidemiology Manufacturing Base Distribution and Headquarters
2.4 Key Companies Artificial Intelligence in Epidemiology Product Offered
2.5 Key Companies Time to Begin Mass Production of Artificial Intelligence in Epidemiology
2.6 Artificial Intelligence in Epidemiology 麻豆原创 Competitive Analysis
2.6.1 Artificial Intelligence in Epidemiology 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Artificial Intelligence in Epidemiology Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence in Epidemiology as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Hardware Technology
3.1.2 Software Technology
3.2 Global Artificial Intelligence in Epidemiology Sales Value by Type
3.2.1 Global Artificial Intelligence in Epidemiology Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Artificial Intelligence in Epidemiology Sales Value, by Type (2019-2030)
3.2.3 Global Artificial Intelligence in Epidemiology Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Disease and Syndromic Surveillance
4.1.2 Infection Prediction and Forecasting
4.1.3 Immunization Information Systems
4.1.4 Public Sentiment Analysis
4.1.5 Environmental Impact Analysis
4.1.6 Drug Discovery, Safety, and Risk Analysis
4.1.7 Monitoring Population and Incidence
4.1.8 Knowledge Representation and Mass Notification
4.2 Global Artificial Intelligence in Epidemiology Sales Value by Application
4.2.1 Global Artificial Intelligence in Epidemiology Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Artificial Intelligence in Epidemiology Sales Value, by Application (2019-2030)
4.2.3 Global Artificial Intelligence in Epidemiology Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Artificial Intelligence in Epidemiology Sales Value by Region
5.1.1 Global Artificial Intelligence in Epidemiology Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Artificial Intelligence in Epidemiology Sales Value by Region (2019-2024)
5.1.3 Global Artificial Intelligence in Epidemiology Sales Value by Region (2025-2030)
5.1.4 Global Artificial Intelligence in Epidemiology Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Artificial Intelligence in Epidemiology Sales Value, 2019-2030
5.2.2 North America Artificial Intelligence in Epidemiology Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Artificial Intelligence in Epidemiology Sales Value, 2019-2030
5.3.2 Europe Artificial Intelligence in Epidemiology Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Artificial Intelligence in Epidemiology Sales Value, 2019-2030
5.4.2 Asia Pacific Artificial Intelligence in Epidemiology Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Artificial Intelligence in Epidemiology Sales Value, 2019-2030
5.5.2 South America Artificial Intelligence in Epidemiology Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Artificial Intelligence in Epidemiology Sales Value, 2019-2030
5.6.2 Middle East & Africa Artificial Intelligence in Epidemiology Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Artificial Intelligence in Epidemiology Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Artificial Intelligence in Epidemiology Sales Value
6.3 United States
6.3.1 United States Artificial Intelligence in Epidemiology Sales Value, 2019-2030
6.3.2 United States Artificial Intelligence in Epidemiology Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Artificial Intelligence in Epidemiology Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Artificial Intelligence in Epidemiology Sales Value, 2019-2030
6.4.2 Europe Artificial Intelligence in Epidemiology Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Artificial Intelligence in Epidemiology Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Artificial Intelligence in Epidemiology Sales Value, 2019-2030
6.5.2 China Artificial Intelligence in Epidemiology Sales Value by Type (%), 2023 VS 2030
6.5.3 China Artificial Intelligence in Epidemiology Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Artificial Intelligence in Epidemiology Sales Value, 2019-2030
6.6.2 Japan Artificial Intelligence in Epidemiology Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Artificial Intelligence in Epidemiology Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Artificial Intelligence in Epidemiology Sales Value, 2019-2030
6.7.2 South Korea Artificial Intelligence in Epidemiology Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Artificial Intelligence in Epidemiology Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Artificial Intelligence in Epidemiology Sales Value, 2019-2030
6.8.2 Southeast Asia Artificial Intelligence in Epidemiology Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Artificial Intelligence in Epidemiology Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Artificial Intelligence in Epidemiology Sales Value, 2019-2030
6.9.2 India Artificial Intelligence in Epidemiology Sales Value by Type (%), 2023 VS 2030
6.9.3 India Artificial Intelligence in Epidemiology Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Informatics
7.1.1 Abbott Informatics Profile
7.1.2 Abbott Informatics Main Business
7.1.3 Abbott Informatics Artificial Intelligence in Epidemiology Products, Services and Solutions
7.1.4 Abbott Informatics Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Informatics Recent Developments
7.2 AdvancedMD
7.2.1 AdvancedMD Profile
7.2.2 AdvancedMD Main Business
7.2.3 AdvancedMD Artificial Intelligence in Epidemiology Products, Services and Solutions
7.2.4 AdvancedMD Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.2.5 AdvancedMD Recent Developments
7.3 Agilent Technologies
7.3.1 Agilent Technologies Profile
7.3.2 Agilent Technologies Main Business
7.3.3 Agilent Technologies Artificial Intelligence in Epidemiology Products, Services and Solutions
7.3.4 Agilent Technologies Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.3.5 Allscripts Healthcare Recent Developments
7.4 Allscripts Healthcare
7.4.1 Allscripts Healthcare Profile
7.4.2 Allscripts Healthcare Main Business
7.4.3 Allscripts Healthcare Artificial Intelligence in Epidemiology Products, Services and Solutions
7.4.4 Allscripts Healthcare Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.4.5 Allscripts Healthcare Recent Developments
7.5 Athenahealth
7.5.1 Athenahealth Profile
7.5.2 Athenahealth Main Business
7.5.3 Athenahealth Artificial Intelligence in Epidemiology Products, Services and Solutions
7.5.4 Athenahealth Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.5.5 Athenahealth Recent Developments
7.6 Autoscribe Informatics
7.6.1 Autoscribe Informatics Profile
7.6.2 Autoscribe Informatics Main Business
7.6.3 Autoscribe Informatics Artificial Intelligence in Epidemiology Products, Services and Solutions
7.6.4 Autoscribe Informatics Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.6.5 Autoscribe Informatics Recent Developments
7.7 Cerner Corporation
7.7.1 Cerner Corporation Profile
7.7.2 Cerner Corporation Main Business
7.7.3 Cerner Corporation Artificial Intelligence in Epidemiology Products, Services and Solutions
7.7.4 Cerner Corporation Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.7.5 Cerner Corporation Recent Developments
7.8 Change Healthcare
7.8.1 Change Healthcare Profile
7.8.2 Change Healthcare Main Business
7.8.3 Change Healthcare Artificial Intelligence in Epidemiology Products, Services and Solutions
7.8.4 Change Healthcare Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.8.5 Change Healthcare Recent Developments
7.9 Cognizant
7.9.1 Cognizant Profile
7.9.2 Cognizant Main Business
7.9.3 Cognizant Artificial Intelligence in Epidemiology Products, Services and Solutions
7.9.4 Cognizant Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.9.5 Cognizant Recent Developments
7.10 CPSI
7.10.1 CPSI Profile
7.10.2 CPSI Main Business
7.10.3 CPSI Artificial Intelligence in Epidemiology Products, Services and Solutions
7.10.4 CPSI Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.10.5 CPSI Recent Developments
7.11 CureMD Healthcare
7.11.1 CureMD Healthcare Profile
7.11.2 CureMD Healthcare Main Business
7.11.3 CureMD Healthcare Artificial Intelligence in Epidemiology Products, Services and Solutions
7.11.4 CureMD Healthcare Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.11.5 CureMD Healthcare Recent Developments
7.12 eClinicalWorks
7.12.1 eClinicalWorks Profile
7.12.2 eClinicalWorks Main Business
7.12.3 eClinicalWorks Artificial Intelligence in Epidemiology Products, Services and Solutions
7.12.4 eClinicalWorks Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.12.5 eClinicalWorks Recent Developments
7.13 e-Mds Inc.
7.13.1 e-Mds Inc. Profile
7.13.2 e-Mds Inc. Main Business
7.13.3 e-Mds Inc. Artificial Intelligence in Epidemiology Products, Services and Solutions
7.13.4 e-Mds Inc. Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.13.5 e-Mds Inc. Recent Developments
7.14 Epic Systems
7.14.1 Epic Systems Profile
7.14.2 Epic Systems Main Business
7.14.3 Epic Systems Artificial Intelligence in Epidemiology Products, Services and Solutions
7.14.4 Epic Systems Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.14.5 Epic Systems Recent Developments
7.15 GE Healthcare
7.15.1 GE Healthcare Profile
7.15.2 GE Healthcare Main Business
7.15.3 GE Healthcare Artificial Intelligence in Epidemiology Products, Services and Solutions
7.15.4 GE Healthcare Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.15.5 GE Healthcare Recent Developments
7.16 Google
7.16.1 Google Profile
7.16.2 Google Main Business
7.16.3 Google Artificial Intelligence in Epidemiology Products, Services and Solutions
7.16.4 Google Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.16.5 Google Recent Developments
7.17 Graphcore
7.17.1 Graphcore Profile
7.17.2 Graphcore Main Business
7.17.3 Graphcore Artificial Intelligence in Epidemiology Products, Services and Solutions
7.17.4 Graphcore Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.17.5 Graphcore Recent Developments
7.18 Greenway Health
7.18.1 Greenway Health Profile
7.18.2 Greenway Health Main Business
7.18.3 Greenway Health Artificial Intelligence in Epidemiology Products, Services and Solutions
7.18.4 Greenway Health Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.18.5 Greenway Health Recent Developments
7.19 IBM
7.19.1 IBM Profile
7.19.2 IBM Main Business
7.19.3 IBM Artificial Intelligence in Epidemiology Products, Services and Solutions
7.19.4 IBM Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.19.5 IBM Recent Developments
7.20 Intel
7.20.1 Intel Profile
7.20.2 Intel Main Business
7.20.3 Intel Artificial Intelligence in Epidemiology Products, Services and Solutions
7.20.4 Intel Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.20.5 Intel Recent Developments
7.21 InterSystems
7.21.1 InterSystems Profile
7.21.2 InterSystems Main Business
7.21.3 InterSystems Artificial Intelligence in Epidemiology Products, Services and Solutions
7.21.4 InterSystems Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.21.5 InterSystems Recent Developments
7.22 Kareo
7.22.1 Kareo Profile
7.22.2 Kareo Main Business
7.22.3 Kareo Artificial Intelligence in Epidemiology Products, Services and Solutions
7.22.4 Kareo Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.22.5 Kareo Recent Developments
7.23 Medhost
7.23.1 Medhost Profile
7.23.2 Medhost Main Business
7.23.3 Medhost Artificial Intelligence in Epidemiology Products, Services and Solutions
7.23.4 Medhost Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.23.5 Medhost Recent Developments
7.24 Meditech
7.24.1 Meditech Profile
7.24.2 Meditech Main Business
7.24.3 Meditech Artificial Intelligence in Epidemiology Products, Services and Solutions
7.24.4 Meditech Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.24.5 Meditech Recent Developments
7.25 Medtronic
7.25.1 Medtronic Profile
7.25.2 Medtronic Main Business
7.25.3 Medtronic Artificial Intelligence in Epidemiology Products, Services and Solutions
7.25.4 Medtronic Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.25.5 Medtronic Recent Developments
7.26 Micron Technology
7.26.1 Micron Technology Profile
7.26.2 Micron Technology Main Business
7.26.3 Micron Technology Artificial Intelligence in Epidemiology Products, Services and Solutions
7.26.4 Micron Technology Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.26.5 Micron Technology Recent Developments
7.27 Microsoft
7.27.1 Microsoft Profile
7.27.2 Microsoft Main Business
7.27.3 Microsoft Artificial Intelligence in Epidemiology Products, Services and Solutions
7.27.4 Microsoft Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.27.5 Microsoft Recent Developments
7.28 NextGen Healthcare
7.28.1 NextGen Healthcare Profile
7.28.2 NextGen Healthcare Main Business
7.28.3 NextGen Healthcare Artificial Intelligence in Epidemiology Products, Services and Solutions
7.28.4 NextGen Healthcare Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.28.5 NextGen Healthcare Recent Developments
7.29 Nvidia
7.29.1 Nvidia Profile
7.29.2 Nvidia Main Business
7.29.3 Nvidia Artificial Intelligence in Epidemiology Products, Services and Solutions
7.29.4 Nvidia Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.29.5 Nvidia Recent Developments
7.30 Optum Inc.
7.30.1 Optum Inc. Profile
7.30.2 Optum Inc. Main Business
7.30.3 Optum Inc. Artificial Intelligence in Epidemiology Products, Services and Solutions
7.30.4 Optum Inc. Artificial Intelligence in Epidemiology Revenue (US$ Million) & (2019-2024)
7.30.5 Optum Inc. Recent Developments
8 Industry Chain Analysis
8.1 Artificial Intelligence in Epidemiology Industrial Chain
8.2 Artificial Intelligence in Epidemiology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Artificial Intelligence in Epidemiology Sales Model
8.5.2 Sales Channel
8.5.3 Artificial Intelligence in Epidemiology Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Abbott Informatics
AdvancedMD
Agilent Technologies
Allscripts Healthcare
Athenahealth
Autoscribe Informatics
Cerner Corporation
Change Healthcare
Cognizant
CPSI
CureMD Healthcare
eClinicalWorks
e-Mds Inc.
Epic Systems
GE Healthcare
Google
Graphcore
Greenway Health
IBM
Intel
InterSystems
Kareo
Medhost
Meditech
Medtronic
Micron Technology
Microsoft
NextGen Healthcare
Nvidia
Optum Inc.
听
听
*If Applicable.
